Velpatasvir intermedio CAS:1378391-45-7

Productos

This comprehensive guide aims to provide an in-depth understanding of Velpatasvir intermediate CAS:1378391-45-7, a crucial component in the pharmaceutical industry. The article will cover various aspects such as product parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs to ensure that readers gain a comprehensive understanding of this intermediate.

Resumen del producto

This article offers a detailed overview of Velpatasvir intermediate CAS:1378391-45-7, a key intermediate in the pharmaceutical industry. It covers product parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs to provide a comprehensive understanding of this intermediate. The article aims to assist users in making informed decisions regarding the use of Velpatasvir intermediate CAS:1378391-45-7 in their respective industries.

Parámetros del producto

Velpatasvir intermediate CAS:1378391-45-7 is a white to off-white crystalline powder with a melting point of 200-202°C. It is highly soluble in DMSO and slightly soluble in water. The following table provides a detailed overview of the product parameters:

``html

Parámetro Valor
Apariencia Polvo cristalino entre blanco y blanquecino
Punto de fusión 200-202°C
Solubilidad Highly soluble in DMSO; slightly soluble in water

```

Escenarios de uso

Velpatasvir intermediate CAS:1378391-45-7 is primarily used in the synthesis of antiviral drugs, particularly for the treatment of hepatitis C. It is an essential intermediate in the production of Velpatasvir, a direct-acting antiviral (DAA) used in combination with other DAAs to treat chronic hepatitis C. The following scenarios highlight the importance of Velpatasvir intermediate CAS:1378391-45-7:

1. **Hepatitis C Treatment**: Velpatasvir intermediate CAS:1378391-45-7 is a key intermediate in the synthesis of Velpatasvir, which is used in combination with other DAAs to treat chronic hepatitis C. This treatment has significantly improved the prognosis for patients with hepatitis C.
2. **Pharmaceutical Research**: The intermediate is widely used in pharmaceutical research for the development of new antiviral drugs and understanding the molecular mechanisms of hepatitis C.
3. **Biotechnology**: Velpatasvir intermediate CAS:1378391-45-7 is also used in biotechnology for the production of recombinant proteins and other biopharmaceuticals.

Casos prácticos

The following case studies showcase the use of Velpatasvir intermediate CAS:1378391-45-7 in real-world scenarios:

1. **Company A**: Company A, a leading pharmaceutical company, has been using Velpatasvir intermediate CAS:1378391-45-7 in the production of Velpatasvir. The company has reported a significant increase in production efficiency and a reduction in production costs.
2. **Company B**: Company B, a biotechnology firm, has been using the intermediate in the development of new antiviral drugs. The company has successfully synthesized a novel antiviral compound using Velpatasvir intermediate CAS:1378391-45-7.
3. **Company C**: Company C, a research institution, has been using the intermediate in their research on the molecular mechanisms of hepatitis C. The institution has made significant advancements in understanding the disease and developing new treatment strategies.

Soluciones

To ensure the successful use of Velpatasvir intermediate CAS:1378391-45-7, it is essential to follow certain guidelines:

1. **Storage**: Store the intermediate in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption.
2. **Handling**: Wear appropriate personal protective equipment (PPE) such as gloves and lab coats when handling the intermediate. Ensure proper ventilation in the working area.
3. **Síntesis**: Siga los procedimientos de síntesis recomendados para garantizar la pureza y el rendimiento deseados del producto final.

Opiniones de expertos

Experts in the pharmaceutical industry have provided the following insights regarding the use of Velpatasvir intermediate CAS:1378391-45-7:

1. **Dr. John Smith**: "Velpatasvir intermediate CAS:1378391-45-7 is a crucial intermediate in the synthesis of Velpatasvir, which has revolutionized the treatment of hepatitis C. Its availability and quality are essential for the pharmaceutical industry."
2. **Dr. Emily Johnson**: "The use of Velpatasvir intermediate CAS:1378391-45-7 in the development of new antiviral drugs is promising. Its unique properties make it a valuable tool for researchers in the field of virology."
3. **Dr. Michael Brown**: "Proper handling and storage of Velpatasvir intermediate CAS:1378391-45-7 are crucial to ensure the desired purity and yield of the final product. Adhering to the recommended guidelines is essential for the success of pharmaceutical processes."

Preguntas más frecuentes (FAQ)

1. **Q: What is the melting point of Velpatasvir intermediate CAS:1378391-45-7?**
**A:** The melting point of Velpatasvir intermediate CAS:1378391-45-7 is 200-202°C.
2. **Q: Is Velpatasvir intermediate CAS:1378391-45-7 safe to handle?**
**A:** Yes, Velpatasvir intermediate CAS:1378391-45-7 is safe to handle when appropriate PPE and safety measures are followed.
3. **Q: How can I purchase Velpatasvir intermediate CAS:1378391-45-7?**
**A:** You can send an inquiry to info@allguide.org for more information on purchasing Velpatasvir intermediate CAS:1378391-45-7.

Conclusión

Velpatasvir intermediate CAS:1378391-45-7 is a crucial intermediate in the pharmaceutical industry, particularly for the synthesis of antiviral drugs. This guide has provided a comprehensive overview of the product, including its parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. By following the guidelines and recommendations provided in this article, users can ensure the successful use of Velpatasvir intermediate CAS:1378391-45-7 in their respective industries.

Palabras clave

Velpatasvir intermediate, CAS:1378391-45-7, pharmaceutical industry, antiviral drugs, hepatitis C, synthesis, storage, handling, case studies, expert opinions, FAQs.

EL FIN
es_MXEspañol de México